REZOLUTE, INC. Shareholders' Equity
REZOLUTE, INC. (RZLT) had Shareholders' Equity of $100.69 million as of 2026-06-30, per its 10-K filed 2026-09-24.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-09-24
- 2026-06-30: Stockholders' Equity Attributable to Parent $100.69M.
- 2026-03-31: Stockholders' Equity Attributable to Parent $116.83M.
- 2025-12-31: Stockholders' Equity Attributable to Parent $128.00M.
- 2025-09-30: Stockholders' Equity Attributable to Parent $147.17M.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2026-06-30 | $100.69M 10-K · filed 2026-09-24 | |
| 2026-03-31 | $116.83M 10-Q · filed 2026-05-12 | |
| 2025-12-31 | $128.00M 10-Q · filed 2026-05-12 | |
| 2025-09-30 | $147.17M 10-Q · filed 2026-02-12 | |
| 2025-06-30 | $162.13M 10-K · filed 2026-09-24 | |
| 2025-03-31 | $82.57M 10-Q · filed 2026-05-12 | |
| 2024-12-31 | $99.59M 10-Q · filed 2026-05-12 | |
| 2024-09-30 | $113.44M 10-Q · filed 2026-02-12 | |
| 2024-06-30 | $121.00M 10-K · filed 2026-09-24 | |
| 2024-03-31 | $70.86M 10-Q · filed 2025-05-13 | |
| 2023-12-31 | $91.73M 10-Q · filed 2025-05-13 | |
| 2023-09-30 | $103.56M 10-Q · filed 2025-02-12 | |
| 2023-06-30 | $116.17M 10-K · filed 2025-09-17 | |
| 2023-03-31 | $127.32M 10-Q · filed 2024-05-15 | |
| 2022-12-31 | $141.26M 10-Q · filed 2024-05-15 | |
| 2022-09-30 | $153.09M 10-Q · filed 2024-02-13 | |
| 2022-06-30 | $149.47M 10-K · filed 2024-09-19 | |
| 2022-03-31 | $51.91M 10-Q · filed 2023-05-11 | |
| 2021-12-31 | $62.27M 10-Q · filed 2023-05-11 | |
| 2021-09-30 | $21.56M 10-Q · filed 2023-02-10 | |
| 2021-06-30 | $26.10M 10-K · filed 2023-09-14 | |
| 2021-03-31 | $29.13M 10-Q · filed 2022-05-12 | |
| 2020-12-31 | $35.89M 10-Q · filed 2022-05-12 | |
| 2020-09-30 | $4.38M 10-Q · filed 2022-02-09 | |
| 2020-06-30 | $7.37M 10-K · filed 2022-09-15 | |
| 2020-03-31 | $10.33M 10-Q · filed 2021-05-17 | |
| 2019-12-31 | $14.69M 10-Q · filed 2021-05-17 | |
| 2019-09-30 | $20.62M 10-Q · filed 2021-02-10 | |
| 2019-06-30 | $1.75M 10-K · filed 2021-09-15 | |
| 2019-03-31 | $4.65M 10-Q · filed 2020-05-14 | $4.65M 10-Q · filed 2019-05-10 |
| 2018-12-31 | -$9.79M 10-Q · filed 2020-05-14 | -$9.79M 10-Q · filed 2019-02-14 |
| 2018-09-30 | -$6.44M 10-Q · filed 2020-02-12 | -$6.44M 10-Q · filed 2018-12-14 |
| 2018-06-30 | -$3.96M 10-K · filed 2020-10-13 | -$3.96M 10-K · filed 2018-10-15 |
| 2018-03-31 | $532.93K 10-Q · filed 2019-05-10 | |
| 2017-12-31 | $3.80M 10-Q · filed 2019-05-10 | |
| 2017-09-30 | $7.81M 10-Q · filed 2019-05-10 | |
| 2017-06-30 | $8.53M 10-K · filed 2019-09-10 | $8.53M 10-K · filed 2017-09-22 |
| 2017-03-31 | $8.46M 10-Q · filed 2017-05-15 | |
| 2016-12-31 | $7.93M 10-Q · filed 2017-02-02 | |
| 2016-09-30 | $8.20M 10-Q · filed 2016-11-14 | |
| 2016-06-30 | $8.77M 10-K · filed 2018-10-15 | |
| 2016-03-31 | $1.12M 10-Q · filed 2016-05-16 | |
| 2015-12-31 | $3.78M 10-Q · filed 2016-02-16 | |
| 2015-09-30 | $6.76M 10-Q · filed 2015-11-16 | |
| 2015-06-30 | $9.05M 10-K · filed 2017-09-22 | |
| 2015-03-31 | $9.70M 10-Q · filed 2015-05-15 | |
| 2014-12-31 | $7.82M 10-Q · filed 2015-02-17 | |
| 2014-09-30 | $5.02M 10-Q · filed 2014-11-12 | |
| 2014-06-30 | $6.41M 10-K · filed 2016-09-28 | |
| 2014-03-31 | $3.41M 10-Q · filed 2014-05-14 | |
| 2013-12-31 | -$4.40M 10-Q · filed 2014-02-13 | |
| 2013-09-30 | -$4.82M 10-Q · filed 2013-11-12 | |
| 2013-06-30 | -$4.16M 10-K · filed 2015-09-28 | |
| 2013-03-31 | -$3.55M 10-Q · filed 2013-05-15 | |
| 2012-12-31 | -$24.47K 10-Q · filed 2013-02-14 | |
| 2012-09-30 | -$15.16K 10-Q · filed 2012-11-19 | |
| 2012-06-30 | -$1.29M 10-K · filed 2014-09-30 | -$5.41K 10-K/A · filed 2012-11-09 |
| 2012-03-31 | $36.00 10-Q · filed 2012-05-15 | |
| 2011-12-31 | -$890.70K 10-K · filed 2013-09-11 | $9.98K 10-Q · filed 2012-02-14 |
| 2011-09-30 | $17.98K 10-Q/A · filed 2011-12-13 | |
| 2011-06-30 | -$505.53K 10-Q · filed 2014-05-14 | $25.37K 10-Q · filed 2011-11-14 |
| 2010-12-31 | -$300.49K 10-K · filed 2013-09-11 | |
| 2010-03-23 | $100.00 10-K · filed 2013-09-11 | |
| 2010-03-09 | $100.00 10-Q · filed 2014-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Turn Therapeutics Inc. (TTRX) | United States | $0.397B | -25.68 |
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| Vogenx, Inc. (VOGX) | United States | $0.355B | |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| ENANTA PHARMACEUTICALS INC (ENTA) | United States | $0.349B | -6.72 |
| Emergent BioSolutions Inc. (EBS) | United States | $0.347B | -2.43 |